These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38472277)
1. Critical review and recommendations for enhancement of the article on novel neurosteroid therapeutics for postpartum depression. Ribeiro TT; de Araújo MB; Nogueira GN; de Matos E Souza FG; Bisol LW Neuropsychopharmacology; 2024 Jun; 49(7):1065-1066. PubMed ID: 38472277 [No Abstract] [Full Text] [Related]
3. Reply to Bisol: Critical review and recommendations for enhancement of the article on novel neurosteroid therapeutics for postpartum depression. Patterson R; Meltzer-Brody S Neuropsychopharmacology; 2024 Jun; 49(7):1063-1064. PubMed ID: 38438593 [No Abstract] [Full Text] [Related]
4. Brexanolone For Postpartum Depression: A Novel Approach and a Call for Comprehensive Postpartum Care. Jarman AF; MacLean JV; Barron RJ; Wightman RS; McGregor AJ Clin Ther; 2020 Jan; 42(1):231-235. PubMed ID: 31910998 [TBL] [Abstract][Full Text] [Related]
5. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience. Lüscher B; Möhler H F1000Res; 2019; 8():. PubMed ID: 31275559 [TBL] [Abstract][Full Text] [Related]
6. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy. Reddy DS; Mbilinyi RH; Estes E Psychopharmacology (Berl); 2023 Sep; 240(9):1841-1863. PubMed ID: 37566239 [TBL] [Abstract][Full Text] [Related]
7. Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women. Reddy DS J Neuroendocrinol; 2022 Feb; 34(2):e13028. PubMed ID: 34506047 [TBL] [Abstract][Full Text] [Related]
8. Postpartum Depression: Identification and Treatment in the Clinic Setting. Kroska EB; Stowe ZN Obstet Gynecol Clin North Am; 2020 Sep; 47(3):409-419. PubMed ID: 32762926 [TBL] [Abstract][Full Text] [Related]
9. Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions. Patterson R; Balan I; Morrow AL; Meltzer-Brody S Neuropsychopharmacology; 2024 Jan; 49(1):67-72. PubMed ID: 37715106 [TBL] [Abstract][Full Text] [Related]
11. Antidepressant use in breastfeeding women. Scrandis DA Nurse Pract; 2018 Oct; 43(10):18-21. PubMed ID: 30234822 [No Abstract] [Full Text] [Related]
12. Comments on "postpartum depression" article by Dr Wisner and colleagues. Henderson P J Clin Psychopharmacol; 2007 Jun; 27(3):321; author reply 322-5. PubMed ID: 17502796 [No Abstract] [Full Text] [Related]
13. Anxiolytic and Anti-depressive Like Effects of Translocator Protein (18 kDa) Ligand YL-IPA08 in a Rat Model of Postpartum Depression. Ren P; Ma L; Wang JY; Guo H; Sun L; Gao ML; Liu YZ; Ma YQ; Li YF; Guo WZ Neurochem Res; 2020 Aug; 45(8):1746-1757. PubMed ID: 32383026 [TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of postpartum depression: current practice and future directions. Tcheremissine OV; Lieving LM Expert Opin Pharmacother; 2005 Oct; 6(12):1999-2005. PubMed ID: 16197354 [TBL] [Abstract][Full Text] [Related]